1ze8

From Proteopedia

proteopedia linkproteopedia link

spinqualitylabelsall models 1ze8, resolution 2.0Å Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image

Carbonic anhydrase II in complex with a membrane-impermeant sulfonamide inhibitor

Contents 1 Overview 2 Disease 3 About this Structure 4 Reference

Overview

Structure for the adduct of carbonic anhydrase II with, 1-N-(4-sulfamoylphenyl-ethyl)-2,4,6-trimethylpyridinium perchlorate, a, membrane-impermeant antitumor sulfonamide, is reported. The phenylethyl, moiety fills the active site, making van der Waals interactions with side, chains of Gln192, Val121, Phe131, Leu198, Thr200. The, 2,4,6-trimethylpyridinium functionality is at van der Waals distance from, the aliphatic chain of Ile91 being involved in strong offset face-to-face, stacking with Phe131. Analyzing X-ray crystal structures of such adducts, two binding modes were observed: some inhibitors bind with their tail, within the hydrophobic half of the active site, defined by residues, Phe131, Val135, Leu198, Pro202, Leu204. Other derivatives bind with their, tail in a different region, pointing toward the hydrophilic half and, making strong parallel stacking with Phe131. This interaction orients the, inhibitor toward the hydrophilic part of the active site. Impossibility to, participate in it leads to its binding within the hydrophobic half. Such, findings are relevant for designing better inhibitors targeting isozymes, II, IX, and XII, some of which are overexpressed in hypoxic tumors.

Disease

Known disease associated with this structure: Osteopetrosis, autosomal recessive 3, with renal tubular acidosis OMIM:[611492]

About this Structure

1ZE8 is a Single protein structure of sequence from Homo sapiens with ZN, HGB, PIU and GOL as ligands. Active as Carbonate dehydratase, with EC number 4.2.1.1 Full crystallographic information is available from OCA.

Reference

Carbonic anhydrase inhibitors: stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II., Menchise V, De Simone G, Alterio V, Di Fiore A, Pedone C, Scozzafava A, Supuran CT, J Med Chem. 2005 Sep 8;48(18):5721-7. PMID:16134940

Page seeded by OCA on Mon Nov 12 20:33:09 2007